O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov

Aim. To compare fecal calprotectin (FC) concentration with laboratory and diagnostic methods in patients with inflammatory bowel diseases (IBD). Materials and methods. The level of FC was measured in 110 patients with established IBD. Crohn diseases (CD) was diagnosed in 50 patients, ileocolitis - i...

Full description

Bibliographic Details
Main Authors: O V Knyazev, A V Kagramanova, I A Korneeva, K K Noskova, S V Belousov, A I Parfenov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2019-04-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/33596/pdf
_version_ 1818063226828488704
author O V Knyazev
A V Kagramanova
I A Korneeva
K K Noskova
S V Belousov
A I Parfenov
author_facet O V Knyazev
A V Kagramanova
I A Korneeva
K K Noskova
S V Belousov
A I Parfenov
author_sort O V Knyazev
collection DOAJ
description Aim. To compare fecal calprotectin (FC) concentration with laboratory and diagnostic methods in patients with inflammatory bowel diseases (IBD). Materials and methods. The level of FC was measured in 110 patients with established IBD. Crohn diseases (CD) was diagnosed in 50 patients, ileocolitis - in 38 and terminal ileitis in 12 individuals. Ulcerative colitis (UC) was diagnosed in 60 patients, total colitis in 35, left-side colitis in 21 and 4 patients have proctitis. Laboratory data include measurement of FC, leukocytes, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), fecal occult blood. All patients underwent colonoileoscopy (CIS) at the start of disease flare and after 12 weeks of treatment. Results and discussion. We found linear correlation between level of FCP and endoscopic activity of CD, analyzing FCP level and endoscopic activity of CD before (during disease flare) and after 12 weeks treatment (r=0.66, p
first_indexed 2024-12-10T14:16:45Z
format Article
id doaj.art-52e63ef23b5443098e7bf7431ca382e5
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-10T14:16:45Z
publishDate 2019-04-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-52e63ef23b5443098e7bf7431ca382e52022-12-22T01:45:19Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422019-04-01914536110.26442/00403660.2019.04.00022930326O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. ParfenovO V Knyazev0A V Kagramanova1I A Korneeva2K K Noskova3S V Belousov4A I Parfenov5A.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of MoscowA.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of MoscowA.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of MoscowA.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of MoscowA.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of MoscowA.S. Loginov Moscow Clinical Research and Practical Center of the Department of Health of MoscowAim. To compare fecal calprotectin (FC) concentration with laboratory and diagnostic methods in patients with inflammatory bowel diseases (IBD). Materials and methods. The level of FC was measured in 110 patients with established IBD. Crohn diseases (CD) was diagnosed in 50 patients, ileocolitis - in 38 and terminal ileitis in 12 individuals. Ulcerative colitis (UC) was diagnosed in 60 patients, total colitis in 35, left-side colitis in 21 and 4 patients have proctitis. Laboratory data include measurement of FC, leukocytes, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), fecal occult blood. All patients underwent colonoileoscopy (CIS) at the start of disease flare and after 12 weeks of treatment. Results and discussion. We found linear correlation between level of FCP and endoscopic activity of CD, analyzing FCP level and endoscopic activity of CD before (during disease flare) and after 12 weeks treatment (r=0.66, phttps://ter-arkhiv.ru/0040-3660/article/viewFile/33596/pdfcrohn diseaseinflammatory bowel diseasesfecal calprotectinulcerative colitis
spellingShingle O V Knyazev
A V Kagramanova
I A Korneeva
K K Noskova
S V Belousov
A I Parfenov
O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
Терапевтический архив
crohn disease
inflammatory bowel diseases
fecal calprotectin
ulcerative colitis
title O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
title_full O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
title_fullStr O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
title_full_unstemmed O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
title_short O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
title_sort o v knyazev a v kagramanova i a korneeva k k noskova s v belousov a i parfenov
topic crohn disease
inflammatory bowel diseases
fecal calprotectin
ulcerative colitis
url https://ter-arkhiv.ru/0040-3660/article/viewFile/33596/pdf
work_keys_str_mv AT ovknyazev ovknyazevavkagramanovaiakorneevakknoskovasvbelousovaiparfenov
AT avkagramanova ovknyazevavkagramanovaiakorneevakknoskovasvbelousovaiparfenov
AT iakorneeva ovknyazevavkagramanovaiakorneevakknoskovasvbelousovaiparfenov
AT kknoskova ovknyazevavkagramanovaiakorneevakknoskovasvbelousovaiparfenov
AT svbelousov ovknyazevavkagramanovaiakorneevakknoskovasvbelousovaiparfenov
AT aiparfenov ovknyazevavkagramanovaiakorneevakknoskovasvbelousovaiparfenov